DeepMed Research

INSTITUTE OF LIVER AND BILIARY SCIENCES

🇮🇳India

Country: 🇮🇳India

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Primary Prophylaxis for Variceal Bleed in Biliary Atresia

Not Applicable

Conditions: Portal Hypertension, Biliary Atresia

Interventions: Drug: Propanolol
Other: Placebo

First Posted Date: 2020-07-31

Last Posted Date: 2021-03-18

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 92

Registration Number: NCT04494763

Locations: 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Efficacy of Vitamin C on AKI Outcomes in Critically Ill Cirrhotics With Multidrug-resistant Bacterial Infections.

Not Applicable

Completed

Conditions: Liver Cirrhosis

Interventions: Drug: Standard medical Treatment
Drug: Vit C

First Posted Date: 2020-07-31

Last Posted Date: 2023-11-03

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 100

Registration Number: NCT04494451

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Sustained Low Efficiency Dialysis Versus Continuous Renal Replacement Therapy for Acute Kidney Injury in Critically Ill Cirrhotics

Not Applicable

Completed

Conditions: Liver Cirrhosis

Interventions: Procedure: Sustained Low Efficiency Dialysis (SLED)
Procedure: Continuous Renal Replacement Therapy

First Posted Date: 2020-07-31

Last Posted Date: 2023-11-03

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 62

Registration Number: NCT04494542

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Tranexamic Acid for Acute Upper Gastrointestinal Bleed in Cirrhosis

Not Applicable

Conditions: Liver Cirrhosis

Interventions: Drug: Tranexamic acid
Other: Standard Medical Treatment
Other: Placebo

First Posted Date: 2020-07-28

Last Posted Date: 2022-01-31

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 600

Registration Number: NCT04489108

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Efficacy of Albumin Plus Midodrine v/s Albumin Alone in Reducing Incidence of Paracentesis Induced Circulatory Dysfunctions in ACLF Patients.

Not Applicable

Conditions: Acute-On-Chronic Liver Failure

Interventions: Biological: Albumin
Other: Placebo
Drug: Midodrine Oral Tablet

First Posted Date: 2020-07-16

Last Posted Date: 2020-07-16

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 150

Registration Number: NCT04474262

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Organ Dysfunction Associated With Intra Abdominal Pressures in Liver Transplantation

Conditions: Intra-Abdominal Hypertension
Liver Diseases
Cirrhosis, Liver
Organ Dysfunction Syndrome

First Posted Date: 2020-07-09

Last Posted Date: 2021-02-04

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 25

Registration Number: NCT04463745

Locations: 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Mean Systemic Filling Pressure Trends in Liver Transplant Recipients

Completed

Conditions: Liver Transplant; Complications
Hemodynamic Instability
Liver Diseases

First Posted Date: 2020-07-08

Last Posted Date: 2022-01-10

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 20

Registration Number: NCT04462874

Locations: 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Rotational Thromboelastometry Guided Blood Component Use in Children With Cirrhosis Undergoing Invasive Procedures: A Randomized Controlled Trial

Not Applicable

Completed

Conditions: Cirrhosis, Liver

Interventions: Procedure: Conventional transfusion methods to guide blood product transfusion pre invasive procedure
Procedure: Rotational Thromboelastometry to guide blood product transfusion pre invasive procedure

First Posted Date: 2020-07-07

Last Posted Date: 2022-06-15

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 60

Registration Number: NCT04460222

Locations: 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Effect of Midodrine on HVPG in Advanced Chronic Liver Disease

Not Applicable

Completed

Conditions: Chronic Liver Disease

Interventions: Drug: Midodrine Oral Tablet

First Posted Date: 2020-07-02

Last Posted Date: 2021-12-14

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 60

Registration Number: NCT04455464

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.

Not Applicable

Conditions: Hepatocellular Carcinoma
Liver Cirrhosis

Interventions: Drug: Lenvatinib
Other: Placebo
Drug: Mebendazole

First Posted Date: 2020-06-23

Last Posted Date: 2021-10-05

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 170

Registration Number: NCT04443049

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy